deferiprone has been researched along with Myelopathy in 1 studies
Deferiprone: A pyridone derivative and iron chelator that is used in the treatment of IRON OVERLOAD in patients with THALASSEMIA.
deferiprone : A member of the class of 4-pyridones that is pyridin-4(1H)-one substituted at positions 1 and 2 by methyl groups and at position 3 by a hydroxy group. A lipid-soluble iron-chelator used for treatment of thalassaemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Deferiprone is an iron chelator that has recently been used to treat patients with infratentorial superficial siderosis (iSS)." | 1.56 | Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis. ( Banerjee, G; Cowley, P; Eleftheriou, P; Farmer, S; Hylton, B; Porter, J; Sammaraiee, Y; Werring, DJ, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sammaraiee, Y | 1 |
| Banerjee, G | 1 |
| Farmer, S | 1 |
| Hylton, B | 1 |
| Cowley, P | 1 |
| Eleftheriou, P | 1 |
| Porter, J | 1 |
| Werring, DJ | 1 |
1 other study available for deferiprone and Myelopathy
| Article | Year |
|---|---|
Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis.
Topics: Adult; Aged; Agranulocytosis; Brain Diseases; Deferiprone; Female; Follow-Up Studies; Hemosiderosis; | 2020 |